6-month Real-world Effectiveness of Fremanezumab in Patients with Migraine who Switched from Another mAb Targeting the CGRP Pathway (Subgroup Analysis from FINESSE) (P4-12.006)

Neurology(2024)

引用 0|浏览2
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要